EligibleTrials

Pragmatic Trial of Obsessive-compulsive Disorder

Recruiting · NCT04539951 · Interventional (participants receive a specific treatment) · Lead sponsor: Shanghai Mental Health Center

View the official record on ClinicalTrials.gov →
Anxiety

Interventions studied

Augment with AripiprazoleAugment with MemantineFluvoxamineSertraline 200 milligram(mg)Sertraline 300 milligram(mg)Venlafaxine

What this trial is about

This study includes a sequenced clinical trial in order to assess the efficacy of several switching or augment strategies when initial treatment is ineffective,and to provide strong evidence for clinical practice and international guidelines for Obsessive-Compulsive Disorder treatments.

Who can take part

Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.